27 January 2025
27 January 2025
The settlement ends the Sackler family’s ownership of the Oxycontin developer Purdue Pharma.
The UK biotech sector raised £3.5bn in 2024, the highest annual total since 2021 when £4.5bn was raised.
The funds will support the development of Ascentage’s pipeline, including its lead candidate olverembatinib to treat blood cancer.
The approval is supported by data from Phase II Study 201 and its long-term extension.
Sacubitril and Valsartan tablets are the generic equivalent of Novartis' Entresto.
Clinical trials are the backbone of discovering new cures and therapies. In this podcast, we learn that navigating the complexities of regulations, quality standards, and logistics doesn't have to feel like a daunting prospect.
Situated in the core of the NC Research Triangle, the site at Camp Helix Innovation Park is a substantial regional investment.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
